PURPOSE: We sought to determine whether survival of patients managed at a large community hospital improved after an affiliated facility opened and its associated programs were initiated. METHODS: Survival data for patients with invasive cancer was obtained from the Hoag Hospital tumor registry for the successive periods 1986-1991 and for 1992-1999 for historical intramural comparisons; national Surveillance, Epidemiology, and End Results (SEER) program data for the same periods were used for contemporary and historical extramural comparisons. RESULTS: We observed survival improved significantly during 1992-1999 compared with 1986-1991 for all patients with invasive cancers (P < .0001), and specifically for cancers of the breast (P = .026), lung (P = .012), prostate (P < .0001), stomach (P = .006), pancreas (P = .0001), and oral cavity (P = .024), with strong trends for improved survival for leukemia (P = .051) and rectal cancer (P = .063). Relative 5-year survival rates increased from 63% during 1986-1991 to 71% during 1992-1999, and were higher for 22 of 24 tumor types during the more recent period (P < .0001). Compared with SEER data, Hoag relative survival for all patients with invasive cancer was 63% versus 58% during 1986-1991, and 71% versus 64% during 1992-1999. Survival for Hoag patients was better than SEER rates for only 50% of malignancies (12 of 24) during 1986-1991 compared with 87% (21 of 24) during 1992-1999 (P = .013). In the most common tumor types, there were substantial improvements in survival for patients with regional disease at diagnosis. Improved survival was associated with earlier diagnosis and increased use of systemic treatment and combined modality therapy. CONCLUSION: Patients with invasive cancer who were treated at an integrated community cancer center had better survival compared with historical survival and patients from the SEER registry. The findings are consistent with the hypothesis that the accelerated dissemination of new information resulted in earlier adoption of improved screening, diagnostic, and multidisciplinary treatment approaches, leading to higher survival rates.
PURPOSE: We sought to determine whether survival of patients managed at a large community hospital improved after an affiliated facility opened and its associated programs were initiated. METHODS: Survival data for patients with invasive cancer was obtained from the Hoag Hospital tumor registry for the successive periods 1986-1991 and for 1992-1999 for historical intramural comparisons; national Surveillance, Epidemiology, and End Results (SEER) program data for the same periods were used for contemporary and historical extramural comparisons. RESULTS: We observed survival improved significantly during 1992-1999 compared with 1986-1991 for all patients with invasive cancers (P < .0001), and specifically for cancers of the breast (P = .026), lung (P = .012), prostate (P < .0001), stomach (P = .006), pancreas (P = .0001), and oral cavity (P = .024), with strong trends for improved survival for leukemia (P = .051) and rectal cancer (P = .063). Relative 5-year survival rates increased from 63% during 1986-1991 to 71% during 1992-1999, and were higher for 22 of 24 tumor types during the more recent period (P < .0001). Compared with SEER data, Hoag relative survival for all patients with invasive cancer was 63% versus 58% during 1986-1991, and 71% versus 64% during 1992-1999. Survival for Hoag patients was better than SEER rates for only 50% of malignancies (12 of 24) during 1986-1991 compared with 87% (21 of 24) during 1992-1999 (P = .013). In the most common tumor types, there were substantial improvements in survival for patients with regional disease at diagnosis. Improved survival was associated with earlier diagnosis and increased use of systemic treatment and combined modality therapy. CONCLUSION:Patients with invasive cancer who were treated at an integrated community cancer center had better survival compared with historical survival and patients from the SEER registry. The findings are consistent with the hypothesis that the accelerated dissemination of new information resulted in earlier adoption of improved screening, diagnostic, and multidisciplinary treatment approaches, leading to higher survival rates.
Authors: Robert O Dillman; Linda D Beutel; Neil M Barth; Cristina de Leon; Audrey A O'Connor; Carol DePriest; Shankar K Nayak Journal: Cancer Biother Radiopharm Date: 2002-02 Impact factor: 3.099
Authors: Robert Dillman; Senthamil Selvan; Patric Schiltz; Cheryl Peterson; Kanoe Allen; Carol Depriest; Edward McClay; Neil Barth; Patric Sheehy; Cristina de Leon; Linda Beutel Journal: Cancer Biother Radiopharm Date: 2004-10 Impact factor: 3.099
Authors: Robert Dillman; Patric Schiltz; Carol DePriest; Neil Barth; Linda Beutel; Cristina de Leon; Audrey O'Connor; Shankar Nayak Journal: Cancer Biother Radiopharm Date: 2004-12 Impact factor: 3.099
Authors: Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun Journal: CA Cancer J Clin Date: 2004 Jan-Feb Impact factor: 508.702
Authors: Robert O Dillman; Christopher M Duma; Patric M Schiltz; Carol DePriest; Robin A Ellis; Kris Okamoto; Linda D Beutel; Cristina De Leon; Sherri Chico Journal: J Immunother Date: 2004 Sep-Oct Impact factor: 4.456
Authors: Robert O Dillman; Gamini Soori; Carol DePriest; Shankar K Nayak; Linda D Beutel; Patric M Schiltz; Cristina de Leon; Audrey A O'Connor Journal: Cancer Biother Radiopharm Date: 2003-10 Impact factor: 3.099
Authors: Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora Journal: Eur Respir J Date: 2017-08-24 Impact factor: 16.671
Authors: Ya-Chen Tina Shih; Chun-Ru Chien; Rocio Moguel; Mike Hernandez; Richard A Hajek; Lovell A Jones Journal: Health Serv Res Date: 2015-06-26 Impact factor: 3.402
Authors: Shamir O Cawich; Peter B Johnson; Sundeep Shah; Patrick Roberts; Milton Arthurs; Trevor Murphy; Kimon O Bonadie; Ivor W Crandon; Hyacinth E Harding; Mohammed Abu Hilal; Neil W Pearce Journal: J Multidiscip Healthc Date: 2014-05-28